Bioatla 

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$0.95
Previous Close
$0.91
Day Range
$0.93-$0.97
52W Range
$0.24-$2.52
Market Cap
$53.6M
Shares Short
4M

Financials

See more
Revenue (12 Mos)
$11M
Revenue Growth (YoY)
31.6%
Gross Profit (12 Mos)
-$51.1M
Diluted EPS
-$1.10

News

See more

Yahoo Finance • 6 days ago

BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025

Yahoo Finance • 2 months ago

BioAtla’s SWOT analysis: oncology biotech’s stock faces cash crunch

Yahoo Finance • 2 months ago

BioAtla to Announce Second Quarter 2025 Financial Results and Provide Business Highlights on August 7, 2025

Yahoo Finance • 3 months ago

BioAtla Presents Data from Ongoing Dose Escalation of BA3182, Dual-Conditionally Binding EpCAM x CD3 Bispecific T-cell Engager, in Patients with Treatment Refractory Metastatic Adenocarcinoma at the 2025 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress

About

CEO
Dr. Jay M. Short Ph.D.
CFO
Mr. Richard A. Waldron
Address
11085 Torreyana Road, San Diego, CA, United States, 92121
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
61